Abiopharma

ANI Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference

New Form DEF 14A - Twist Bioscience Corp Filed: 2026-01-06 AccNo: 0001581280-26-000006 Size: 7 MB

New Form 424B5 - Praxis Precision Medicines, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001307 Size: 620 KB

New Form 3 - ELI LILLY & Co Filed: 2026-01-06 AccNo: 0001724605-26-000002 Size: 682 KB

Director Schenkein David P 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

Integer Holdings Corporation (ITGR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Director GOLDSTEIN JOSEPH L 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

New Form S-8 POS - Mersana Therapeutics, Inc. Filed: 2026-01-06 AccNo: 0001104659-26-001306 Size: 30 KB

New Form SCHEDULE 13D/A - AVENUE THERAPEUTICS, INC. Filed: 2026-01-06 AccNo: 0001104659-26-001305 Size: 14 KB

Director RYAN ARTHUR F 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Director COLES N ANTHONY 🟢 acquired 2.1K shares (1 derivative) of REGENERON PHARMACEUTICALS, INC. (REGN) at $772.76 ($1.5M) Transaction Date: Jan 02, 2026 | Filing ID: 000002

(99% Neutral) Regional Health Properties, Inc. (RHE$A) Announces Regulatory Update

Bragg Kimberly 🟢 acquired 9.1K shares (1 derivative) of Imunon, Inc. (IMNN) at $3.95 Transaction Date: Jan 02, 2026 | Filing ID: 000615